tiprankstipranks
Genscript Biotech Plans Key Mid-Year Meeting
Company Announcements

Genscript Biotech Plans Key Mid-Year Meeting

Genscript Biotech (HK:1548) has released an update.

Pick the best stocks and maximize your portfolio:

Genscript Biotech Corporation has scheduled a board meeting for August 9, 2024, to discuss and potentially approve the interim financial results for the first half of the year, as well as to consider declaring an interim dividend. The meeting will involve the company’s directors and will address the performance of both the company and its subsidiaries. The announcement was made in both English and Chinese, with the English version taking precedence in case of discrepancies.

For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech Announces CEO Resignation and Leadership Changes
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech Aligns Interests with Restricted Share Grant
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App